# US 2016/0237469 A1 · Microbial analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0237469 A1
- Document ID: US20160237469A1
- Status: Published application
- Kind: A1
- Application number: 15/028,052
- Filed: 2014-10-09
- Published: 2016-08-18
- Earliest claimed: 2013-10-09
- Assignees: Kratos Analytical Limited
- Applicants: Kratos Analytical Limited
- Inventors: Gerald STUBIGER; Omar BELGACEM
- Web page: https://patentgrep.com/patent/US20160237469A1

## CPC

- C12Q 1/04: Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)}
- G01N 33/6851: {Methods of protein analysis involving laser desorption ionisation mass spectrometry}
- G01N 33/92: involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones G01N33/743)}
- H01J 49/0418: {for laser desorption, e.g. matrix-assisted laser desorption/ionisation [MALDI] plates or surface enhanced laser desorption/ionisation [SELDI] plates}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)

## Abstract

The present invention is concerned with a method of identifying microbial strains (e.g. from a cell culture), the method comprising; i) a lipid extraction step, comprising extraction of phospholipids from the microbe, suitably with an extraction composition comprising more than 50 vol % MeOH; ii) a sample preparation step, comprising preparation of a MALDI sample incorporating the extracted lipids; iii) a data gathering step, comprising performing MALDI-based mass spectrometry on the MALDI sample, and iv) a microbe identification step, comprising analysis of the mass spectrometry data to characterise or identify the microbial strain. Suitably the method also includes extracting proteins from the microbes and analysing the extracted proteins using MALDI-based mass spectrometry so as to obtain not only lipid m/z data but also protein m/z data.

## Claims

### Claim at position 1

1-2. (canceled)

### Claim 3

A method of analysing microbes, the method comprising;
i) a lipid extraction step, comprising addition of a extraction composition to the microbes to extract lipids, wherein the extraction composition comprises more than 50 vol % alcohol or more than 50 vol % ether;
ii) a sample preparation step, comprising preparation of a MALDI sample incorporating the extracted lipids; and
iii) a data gathering step, comprising performing MALDI-based mass spectrometry on the MALDI sample.

### Claim 4 (depends on 3)

A method according to claim 3, wherein the lipid extraction step comprises extraction of proteins from the microbe, the sample preparation step includes preparation of a further MALDI sample incorporating the extracted proteins, and the data gathering step includes performing MALDI-based mass spectrometry on the MALDI samples so as to obtain mass spectrometry data relating to the lipid composition and mass spectrometry data relating to the protein composition.

### Claim 5 (depends on 3)

A method according to claim 3, wherein the extraction composition comprises more than 70 vol % methanol or ethanol.

### Claim 6 (depends on 3)

A method according to claim 3, wherein the lipid extraction step extracts phospholipids , suitably wherein the lipid extraction step further extracts neutral lipids.

### Claim 7 (depends on 3)

A method according to claim 3, wherein the organic extraction compositions more than 50 vol % alcohol, and the alcohol volume comprises or consists of methanol.

### Claim 8

(canceled)

### Claim 9 (depends on 3)

A method according to claim 3, wherein in the data gathering step the sample is negatively ionised.

### Claim 10 (depends on 9)

A method according to claim 9, wherein in the sample preparation step, the prepared MALDI sample comprises 9AA matrix material, and optionally wherein the sample additionally comprises pyridine.

### Claim 11 (depends on 3)

A method according to claim 3, wherein in the data gathering step the sample is positively ionised, and wherein in the sample preparation step, the prepared MALDI sample comprises ATT matrix material, and optionally wherein the sample additionally comprises di-ammonium hydrogen citrate.

### Claim 12 (depends on 3)

A method according to claim 3, wherein in the data gathering step the m/z range over which data is obtained is from about 100 to about 3000 in the MS1 30 spectrum.

### Claim 13 (depends on 3)

A method according to claim 3, wherein in the data gathering step, the MALDI-based mass spectrometry uses one or more of the following techniques;
a) Quadrupole ion trapping (QIT);
b) Time of flight measurement (TOF);
c) Reflection time of flight measurement (RTOF);
d) Orbitrap mass spectrometry;
e) Fourier transform mass spectrometry (FTMS);
f) Tandem mass spectrometry (MS/MS); and
g) Collision induced dissociation

### Claim 14 (depends on 3)

A method according to claim 3, wherein in the sample preparation step, the sample is prepared on a polymeric or plastics MALDI sample plate.

### Claim 15 (depends on 3)

A method according to claim 3,
wherein
the lipid extraction step comprises addition of a methanol solution or a methanol/acetone composition to the microbes, and/or
the sample preparation step comprises addition of 9AA or ATT matrix material to the extracted lipids, and/or
in the data gathering step, the m/z range scanned is from about 100 to about 3000 in the MS 1 spectrum.

### Claim 16 (depends on 4)

A method according to claim 4, comprising addition of CHCA matrix material to the extracted proteins.

### Claim 17 (depends on 3)

A method according to claim 3, further comprising a microbe identification step, comprising comparison of the mass spectrometry data with known values to characterise or identify the microbe.

### Claim 18 (depends on 3)

A method according to claim 3, wherein the microbe is a bacterium.

### Claim at position 18

19-20. (canceled)

### Claim 21 (depends on 3)

A method according to claim 3, wherein the sample is negatively ionised in the data gathering step.

### Claim 22

(canceled)

### Claim 23

A method of analysing microbes, the method comprising;
i) an extraction step, comprising extraction of lipids and proteins from the microbes;
ii) a sample preparation step, comprising preparation of one or more MALDI samples incorporating the extracted lipids and/or the extracted proteins; and
iii) a data gathering step, comprising performing MALDI-based mass spectrometry on the one or more MALDI sample(s) so as to obtain mass spectrometry data on the lipid composition of the microbes and on the protein composition of the microbes.

### Claim 24 (depends on 23)

A method according to claim 23, wherein the mass spectrum data for the lipids and the mass spectrum data for the proteins is merged and wherein the method includes iv) a microbe identification step, comprising analysis of the merged mass spectrometry data to characterise or identify the microbial strain.

### Claim 25 (depends on 3)

A kit of parts comprising
(i) a MALDI matrix material, and optionally a co-matrix material,
(ii) a sample plate,
(iii) a calibration mixture of cationic and anionic PL standards, and
(iv) a set of instructions for completing a method according to claim 3.

### Claim 26 (depends on 25)

A kit according to claim 25, wherein
the matrix material is selected from ATT, THAP and 9AA and the optional co matrix material selected from DAHC, GUA and sodium or lithium acetate, and/or
one or more sample plates are included, wherein each is a 48-well target slide, and/or
organic solvents for lipid extraction and/or matrix material dissolution are included.
